Xin Lang Cai Jing·2025-08-12 01:59Core Viewpoint - The medical device sector is experiencing a strong rebound, with companies like Sanxin Medical and Sainuo Medical seeing stock increases of over 10% due to supportive policy signals for innovation in the industry [1] Group 1: Market Performance - Sanxin Medical and Sainuo Medical both saw stock price increases exceeding 10% [1] - Other companies such as Mailland, Zhonghong Medical, Zhenghai Biological, Shanhaishan, David Medical, and Nanwei Medical experienced stock price increases of over 5% [1] Group 2: Policy Impact - CITIC Securities research report indicates that recent high-level discussions have emphasized principles such as "anti-involution" and "optimizing centralized procurement without solely focusing on low prices" [1] - These policy signals are seen as a clear turning point for supporting the development of the innovative drug and medical device industry [1] Group 3: Industry Outlook - The medical device sector is expected to see a recovery in both valuation and performance as a result of these supportive policies [1]